Monday, November 7, 2011

Psychologist Accused of Fraud on ‘Astonishing Scale’

The worst fears came true. A Dutch committee that has spent the past 6 weeks investigating one of the Netherlands’ leading social psychologists has concluded in a report this week that he made up or manipulated data in dozens of papers over nearly a decade.

              Diederik Stapel was originally suspended from his position at Tilburg University in the Netherlands in September after three junior researchers reported that they suspected scientific misconduct in his work. After being confronted with the accusations, Stapel reportedly told university officials that some of his papers contained falsifi ed data. The university launched an investigation, as did the University of Groningen and the University of Amsterdam, where Stapel had worked previously.

              The Tilburg commission released an interim report on 31 October, which includes preliminary results from all three investigations. The investigators found evidence of misconduct on an “astonishing scale,” the report says. Stapel made up data in “several dozens of publications,” the committee found, and 14 of the 21 Ph.D. theses he supervised are tainted.
          Stapel issued a statement the same day, saying he “failed as a scientist” and is ashamed of his actions. He has cooperated to an extent by giving investigators a list of papers that used fraudulent data, the report says. The ongoing investigations plan to examine more than 150 publications that Stapel has co-authored, including a paper earlier this year in Science (8 April, p. 251) on the influence of a messy environment on prejudice. (Science issued an Editorial Expression of Concern about the paper this week.) The fraud will cause “huge damage,” says Susan Fiske, a social psychologist at Princeton University. “His work is very central—or was.”                 

           Stapel’s studies encompassed a broad range of attention-catching topics, including how a position of power influences moral thinking. The committee, which interviewed dozens of Stapel’s former students and colleagues, concluded that Stapel acted alone. The report says he would discuss experimental designs in detail with collaborators and would claim to conduct the surveys at high schools and universities with which he had special arrangements. The experiments, however, never took place, and Stapel gave collaborators made up data sets, investigators allege. In other instances, the report says, he told colleagues that he had an old data set lying around that he hadn’t had a chance to analyze. When Stapel did conduct actual experiments, the committee found evidence that he manipulated results.
Many of Stapel’s students were simply given data to analyze and graduated without having ever run an experiment, the report says. The commission writes that Stapel was “absolute lord of the data” in his collaborations. Colleagues or students who asked to see raw data told the commission they were given excuses or even threatened and insulted.
              At least two earlier groups of whistleblowers questioned Stapel’s work, the report notes, but no one followed up. On careful inspection, many of Stapel’s data sets have improbable effect sizes and other statistical irregularities, the report says. Among Stapel’s colleagues, the description of data as too good to be true “was a heartfelt compliment to his skill and creativity,” the report says.
The report recommends that the universities look into criminal charges based on the misuse of research funds and possible harm to Stapel’s students resulting from the fraud. The University of Amsterdam, where Stapel received his Ph.D., has not yet determined whether his dissertation is fraudulent. The committee suggests that the university consider revoking Stapel’s degree, however, based on “unbecoming” conduct.

SOURCE : SCIENCE MAGAZINE VOL 334

The Brain’s Social Network

Keeping track of an extended network of Facebook friends, Twitter followers, and LinkedIn connections—not to mention those old-fashioned face-to-face relationships with neighbors and offi ce mates—can certainly feel like a mental challenge. But does having a larger, more complex social network actually change the brain? A new study with macaques suggests it can.
On page 697, a team led by neuroscientists Jérôme Sallet and Matthew Rushworth of the University of Oxford in the United Kingdom reports that housing monkeys in larger groups increased the amount of gray matter in several parts of the brain involved in social cognition. Previous research has implicated these regions in a variety of tasks, from interpreting facial expressions and gestures to predicting what other individuals intend to do. The researchers also found correlations between gray matter volume and a monkey’s dominance rank within its group, suggesting that beefi ng up neural circuitry in certain areas somehow promotes or enables social success.
The work may help to resolve a quandary raised by a handful of recent studies that have correlated variations in human brain anatomy with social network size, some experts say. Those studies couldn’t resolve which causes which. That is, do certain neuroanatomical features predispose people to building a large social network, or does having a large network cause certain brain regions to expand? “In humans, it’s difficult to show anything but a correlation,” says Lisa Barrett, a neuroscientist at Northeastern University in Boston. Although she has some reservations about the design of the experiment, Barrett says “this clearly shows changes in gray matter in response to experience.”
The new monkey study and the recent human research point to many of the same regions of the temporal and frontal lobes as potential contributors to social success. As researchers continue to refine this picture of the brain’s social circuitry, there may be implications for hypotheses about brain evolution, such as the social brain hypothesis, which posits that the increasing complexity of social networks in primates in general and humans in particular drove the expansion of the cerebral cortex, or at least certain parts of it.
In the Science study, Sallet and colleagues used magnetic resonance imaging (MRI) scans to look for variations in brain anatomy in 23 adult monkeys housed in groups of two to seven, plus one monkey housed alone. The monkeys were originally purchased in groups of different sizes and used in experiments by other researchers at Oxford, and their housing arrangements were determined by the requirements of these studies, Sallet says. Each monkey was scanned after it had been in a group of a constant size for 15 months on average. Before-and-after scans were not feasible due to the constraints of the various experiments, Sallet says.

Another important caveat, Barrett and others say, is that the monkeys were not assigned to groups at random. To keep the peace, caretakers may have tended to put sociable animals together in larger groups and kept the mean ones alone or in pairs, says Michael Tomasello, a psychologist at the Max Planck Institute for Evolutionary Anthropology in Leipzig, Germany. “Preexisting characteristics of the individuals in the groups might plausibly be what is being measured, not any effects of social experience,” Tomasello says. Sallet and colleagues insist that the housing assignments were made independently of any social characteristics of the animals and were as random as possible given their circumstances (although they note that one especially large group of 13 was split up to prevent fights).
Monkeys housed in larger groups had more gray matter in several regions of the temporal cortex, including the superior temporal sulcus (STS). Previous monkey studies have found that neurons in this region fire in response to faces and body movements and seem to track where other individuals are directing their attention. Gray matter may increase in the STS in response to a growing need to decode the expressions, gestures, and movements of more individuals as social network size increases, the researchers suggest.
Human MRI studies have also linked the STS to social network size. In a study published online 19 October in the Proceedings of the Royal Society B, Ryota Kanai and Geraint Rees of University College London and colleagues report that the right STS is one of several temporal lobe regions in which gray matter density correlates with the size of people’s Facebook networks.
Sallet and colleagues also found increased gray matter in the amygdala of monkeys housed in larger groups. This structure deep in the temporal lobes is best known as a hub of emotional regulation. The recent study by Kanai and Rees implicated the amygdala as well, as did a study published online by Barrett and colleagues in December in Nature Neuroscience. They found greater amygdala volume in people with larger and more complex social networks, as measured by questionnaires. Barrett suggests that the amygdala’s role in individuals and events that are worth paying attention to and remembering. For example, she says, your amygdala might help you scan a crowded party for friends and foes.
The Oxford researchers also found  more gray matter in the rostral prefrontal cortex in monkeys housed in larger groups. In humans, regions of prefrontal cortex have been linked to “theory of mind,” or the recognition that other individuals have beliefs and intentions that may differ from one’s own. Monkeys don’t appear to possess this talent, but more gray matter in this region did seem to confer a social advantage. In a subset of 11 male monkeys, the researchers found that those with more gray matter in the rostral prefrontal cortex tended to be more dominant.
The prefrontal cortex may also play a role in social success in humans. A study published in the 15 August issue of Neuro Image found that people with more gray matter in the ventromedial prefrontal cortex (and a few other regions of temporal and frontal cortex) performed better on tests requiring multiple layers of mind reading, such as determining from a short story whether Sam thought Harry intentionally gave him misleading directions. That study, led by Oxford evolutionary anthropologist Robin Dunbar, also found that people with more gray matter in these regions tend to have larger social networks, which the researchers assessed by asking participants to write down the initials of everyone with whom they’d had a social interaction in the past month, using their cell phones to jog their memories.
“With these several studies, you’re seeing a lot of the same sorts of brain areas implicated in correlations with social network size,” says Robert Barton, who studies brain evolution at Durham University in the United Kingdom. But the evolutionary implications aren’t yet clear, Barton says. “We don’t know what the relationship is between these studies that look at individual differences and the comparative studies that look at differences between species.” It remains to be seen, for example, whether the same regions that are expanded in individuals with large social networks are the same ones that are expanded in large-brained social primates compared with less social species, Barton says.
Dunbar sees it differently: “Variations among individuals provide the platform for selection to act on.” He views the recent findings as strong support for the social brain hypothesis, of which he is an ardent advocate. “The ability to form cooperative networks of individuals is what’s driving the evolution of big brain sizes,” Dunbar says. “The brain is a social tool.”

SOURCE : SCIENCE MAGAZINE VOL 334

Sunday, November 6, 2011

Panel Endorses Anthrax Vaccine Study in Children

It’s an ethically fraught question almost without precedent in modern medical research: Should children be enrolled in a clinical trial of the anthrax vaccine, which is almost certain not to help them and may harm them? Or should the U.S. government gamble and wait for a possible attack before exposing children to the vaccine for the very first time? Last week, the full National Biodefense Science Board (NBSB) voted 12–1 in favor of a trial assuming its ethics are approved by a review board, saying that it was too uneasy to risk a mass science experiment on thousands of children after a bioterror strike, even if some consider that possibility remote.
“Before vaccines are given to children, they are tested in children,” says Daniel Fagbuyi, the medical director of disaster preparedness and emergency management at Children’s National Medical Center in Washington, D.C. “We do not want to set a new precedent.” Fagbuyi chaired an NBSB working group that in September recommended a clinical trial.
Last week’s vote isn’t binding, and even if a study goes forward, the U.S. Department of Health and Human Services (HHS) will need to jump through many hoops to get it up and running. Although clinical trials are all about gathering information that benefits others, rules for studies on children are more stringent than for those on adults. It’s legally and ethically challenging to offer a child an experimental treatment that’s even slightly risky if the chance of benefiting is all but nonexistent, as is the case with the anthrax vaccine.
The vaccine has been around for decades, and more than 2 million adults, mostly military personnel, have received it. But HHS and others who fret about a bioterror attack worry that this isn’t enough. A quarter of the U.S. population is under 18, and no one has examined how children and teenagers react to the vaccine—for instance, whether they need different doses to ensure safety and effectiveness.
There is considerable variation in the way vaccines are administered to people of different ages. With the tetanus vaccine, “the same dose is given to a 2-month-old infant as an NFL football player,” says John Grabenstein, senior medical director for adult vaccines at Merck and a member of the NBSB. For the hepatitis B vaccine, the dose is lower in children; for flu, it may also be lower and is sometimes given as two small doses, rather than one larger one. “There’s enough idiosyncrasies that you can’t assume” how children will react to a vaccine based on what you know in adults, says Grabenstein, who voted in favor of a clinical trial. “The only way to know is to try.”
In the bioterror world, a similar question has come up at least once before. Soon after the 11 September attacks and the anthrax mailings, officials were concerned about weaponized smallpox. There wasn’t enough of the existing smallpox vaccine, Dryvax, to go around, so the government considered whether to test it in 2- to 5-year-olds to see whether they could gain the same benefi t from a smaller dose, thus stretching supplies. In some ways the proposed trial was more problematic than an anthrax study, says Douglas Diekema, a pediatrician and bioethicist at Seattle Children’s Research Institute: Smallpox vaccine is considered riskier than anthrax vaccine, and many felt the chance of a smallpox attack was much more remote than one using anthrax. For various reasons, the smallpox study never went forward. Fagbuyi finds the comparison lacking. Anthrax vaccine, he says, is “totally different than Dryvax” and has been tested in very large groups of people. The U.S. Centers for Disease Control and Prevention (CDC) is wrapping up a study it began 11 years ago in healthy adults, analyzing vaccine safety and whether people can produce suffi cient protective antibodies with fewer doses of the vaccine, and by receiving it in muscle rather than under the skin, which results in fewerside effects. “This is a very safe vaccine,” and side effects, like redness and swelling or brief fever, are similar to what’s seen in many childhood vaccines, says Nancy Messonnier, chief of CDC’s bacterial vaccine branch. Like vaccines that protect against diphtheria and tetanus, for example, the anthrax vaccine is made with a protein from anthrax bacteria that’s harmless on its own.
None of this appeases pediatricians and bioethicists who consider an anthrax vaccine trial in children wrongheaded. “These children are going to be exposed to a vaccine from which they have no chance of benefiting. The only possible outcome is that nothing will happen, … or they’ll have a safety issue,” says Paul Offit, an infectious disease specialist at the Children’s Hospital of Philadelphia in Pennsylvania, who often speaks out in favor of childhood vaccination. Diekema agrees. Scientifically, a trial like this makes sense, because it’s the best way to gather the necessary information. That said, “it’s a difficult study to justify.”
Then there’s the question of who would volunteer their children. Fagbuyi, who served in Iraq and received the anthrax vaccine himself, says that some military members, first responders, and scientists working
with anthrax—many of whom get the vaccine now—have expressed interest in having their children vaccinated, too. They may be comfortable enrolling them in an anthrax study, if it gets off the ground.

SOURCE : SCIENCE MAGAZINE VOL 334

Thursday, November 3, 2011

Light Pollution’s Medical Effects

Excessive light is a problem for everyone, not just amateur astronomers-

People  well aware of the  many problems associated with light  pollution, such as energy waste, sky glow, and environmental impact. But not many  people know about the burgeoning growth  of research that demonstrates direct  human-health issues related to excess  light. In fact, health effects might ultimately be the most important reason to  control light pollution. The energy wasted  by excessive lighting is produced mainly by burning fossil fuels, leading directly to air pollution that causes higher asthma  rates and increased respiratory problems  for people with lung disease and other  medical issues.   
Glare is the most common health  safety problem resulting from poorly  designed outdoor lighting. You have probably noticed poor vision stemming from  glare on a dirty windshield. Over time, calcifications build up in the lenses of  our eyes, which eventually develop into  a cataract. These calcifications and other  lens and eye imperfections scatter light  in a similar fashion to a dirty windshield.  This effect grows more severe with age,  and it’s the primary reason why elderly  people have a diffi cult time driving at  night near poorly designed streetlights.  Most people with this problem are not  even aware that glare is the main cause  of their poor night vision, and that they  could drive more safely if streetlights were  properly designed. Recognizing this fact,  the American Medical Association (AMA)  adopted a resolution in 2009 urging full  shielding for all public street lighting.
A hot new area of research is how  night light disrupts our circadian rhythm.  Numerous papers over the past 15 years  have led medical researchers to conclude  that night light increases the incidence  of certain cancers, most notably breast  cancer. In fact, researchers now estimate  that up to 30% of breast cancers may be  due to light at night suppressing circadian rhythm. The research basis for this  conclusion has become so compelling that  the World Health Organization recently  declared circadian-rhythm disruption to  be a class 2A carcinogen — placing it on  the same level of severity as the effects of  tobacco smoke on lung cancer.
The biochemical mechanism for this  problem has been thoroughly researched  and is thought to result from the suppression of melatonin production by the  pineal gland in the center of our brain.  This gland produces melatonin while we sleep. Repeated exposure to light at night  markedly suppresses melatonin production. Previous research has shown that  this hormone helps the immune system  suppress the development of several types of cancers.

SOURCE : SKY & TELESCOPE MAGAZINE SEPTEMBER 2011

The Real Science behind Scientology

In the 1990s I had the opportunity to dine with the late musician Isaac Hayes, whose career fortunes had just made a stunning turnabout upward, which he attributed to Scientology. It was a glowing testimonial by a sincere follower of the Church, but is it evidence that Scientology works? Two recently published books argue that there is no science in Scientology, only quasireligious doctrines wrapped in New Age flapdoodle masquerading as science. The Church of Scientology, by Hugh B. Urban, professor of religious studies at Ohio State University, is the most scholarly treatment of the organization to date, and investigative journalist Janet Reitman’s Inside Scientology is an electrifying read that includes eye-popping and well-documented tales of billion-year contracts, aggressive recruitment programs and abuse of staffers.
The problem with testimonials is that they do not constitute evidence in science. As social psychologist Carol Tavris told me, “Every therapy produces enthusiastic testimonials because of the justification-of-effort effect. Anyone who invests time and money and effort in a therapy will say it helped. Scientology might have helped Isaac Hayes, just as psychoanalysis and bungee jumping might have helped others, but that doesn’t mean the intervention was the reason. To know if there is anything special about Scientology, you need to do controlled studies—randomly assigning people to Scientology or a control group (or a different therapy) for the same problem.” To my knowledge, no such study has been conducted. The real science behind Scientology seems to be an understanding of the very human need, as social animals, to be part of a supportive group—and the willingness of people to pay handsomely for it.
If Scientology is not a science, is it even a religion? Well, it does have its own creation myth. Around 75 million years ago Xenu, the ruler of a Galactic Confederation of 76 planets, transported billions of his charges in spaceships similar to DC-8 jets to a planet called Teegeeack (Earth). There they were placed near volcanoes and killed by exploding hydrogen bombs, after which their “thetans” (souls) remained to inhabit the bodies of future earthlings, causing humans today great spiritual harm and unhappiness that can be remedied through special techniques involving an Electropsychometer (E-meter) in a process called auditing.
Thanks to the Internet, this story—previously revealed only to those who paid many thousands of dollars in courses to reach Operating Thetan Level III (OT III) of Scientology—is now so widely known that it was even featured in a 2005 episode of the animated TV series South Park. In fact, according to numerous Web postings by ex-Scientologists, documents from court cases involving followers who reached OT III and abundant books and articles by ex members who heard the story firsthand and corroborate the details, this is Scientology’s Genesis. So did its founder, writer L. Ron Hubbard, just make it all up—as legend has it—to create a religion that was more lucrative than producing science fiction?
Instead of printing the legend as fact, I recently interviewed the acclaimed science-fiction author Harlan Ellison, who told me he was at the birth of Scientology. At a meeting in New York City of a sci-fi writers’ group called the Hydra Club, Hubbard was complaining to L. Sprague de Camp and the others about writing for a penny a word. “Lester del Rey then said half-jokingly, ‘What you really ought to do is create a religion because it will be tax-free,’ and at that point everyone in the room started chiming in with ideas for this new religion. So the idea was a Gestalt that Ron caught on to and assimilated the details. He then wrote it up as ‘Dianetics: A New Science of the Mind’ and sold it to John W. Campbell, Jr., who published it in Astounding Science Fiction in 1950.”
To be fair, Scientology’s Xenu story is no more scientifically untenable than other faiths’ origin myths. If there is no testable means of determining which creation cosmogony is correct, perhaps they are all astounding science fictions.

SOURCE : SCIENTIFIC AMERICAN MAGAZINE NOVEMBER 2011

Tuesday, November 1, 2011

Ralph M. Steinman – Inspiring Scientist

 On 30 September 2011, just days short of the announcement that he had been awarded the Nobel Prize for his discovery of dendritic cells, Ralph Steinman lost his nearly 5-year-long battle with pancreatic cancer. Although this disease claims the lives of 85% of those it afflicts within 1 year of diagnosis, it was not surprising to many of us who knew him that Ralph beat the odds for so long and got so much accomplished while doing so.
Ralph was born in 1943 in Sherbrook, Quebec, to Jewish immigrants from Eastern Europe. As is true for many children of immigrants, he chose to forsake the family owned business (a general store) and strike out in a new direction—medicine. After graduating from McGill University, he attended Harvard Medical School and became interested in how the immune system protects against disease. After completing internship and residency training at the Massachusetts General Hospital, Ralph chose to pursue a career in science and joined the laboratory of Zanvil Cohn and James Hirsch at The Rockefeller University in 1970. The Cohn- Hirsch lab had a remarkable and long history at Rockefeller. It was originally headed by Oswald Avery, who discovered the transforming principle (that DNA is the genetic material), and later by Rene Dubos, who discovered the first antibiotic, Gramacidin, and was the mentor of Hirsch and Cohn. Long before “translational science” became a catch phrase, Avery was one of the few who actually combined basic science with a focus on implications for elucidating fundamental disease processes. Ralph embraced this tradition enthusiastically.
The focus of the Hirsch-Cohn lab was on cells of the innate immune system, particularly the macrophage and its role in defense against infectious agents and as a mediator of inflammation. The approach was not limited to immunology but embraced cell biology and biochemistry, an influence that proved to be a defining one for Ralph.
In the early 1970s, it was becoming clear that adaptive immune responses were triggered by “antigen-presenting cells” and that the responses were restricted by molecules of the major histocompatibility complex (MHC). Antigenic peptides were shown to combine with MHC to produce a complex that serves as a ligand for specific T cells. Given their central role in innate immune responses and ability to capture and degrade invading microorganisms, it seemed logical that the macrophage would also play the central role in antigen presentation. Ralph characterized how macrophages handled antigens, and his fi ndings had ripple effects far beyond macrophage biology. He found that macrophages (and other cell types) continuously internalized membrane during endocytosis, but recycled it intact back to the cell surface. Yet, antigen internalized by macrophages was efficiently degraded in lysosomes, seemingly at odds with the formation of peptide-MHC complexes.
             Ralph and his colleagues determined that the cell actually responsible for antigen presentation was not a macrophage but a distinctive cell type with long dendrites that was rich in MHC molecules but poor in lysosomes (as compared with macrophages). Electron microscopy revealed a morphologically similar cell in lymphoid organs, which was eponymously referred to as the “dendritic cell” (DC). Ralph led an intrepid and dedicated group of colleagues to develop methods to culture DCs, isolate them, and characterize their properties and functions. Given that they were far less numerous than macrophages in the initial preparations, and given that the zeitgeist of the field assumed that the T cell stimulatory functions Ralph had ascribed to DCs were actually the purview of macrophages, gaining acceptance for this concept was a long uphill battle. The opposition may have helped contribute to the incredible elegance and incisiveness that characterized Ralph’s work, but it also led to career challenges and personal disappointments. Ralph’s unbelievable level of dedication, courage, and stubbornness, combined with wonderful support from his family and from Cohn, enabled the DC ultimately to come into its own and join the pantheon of the most important cells in the immune system.
                   Ralph’s infectious enthusiasm and scientific leadership was inspiring to increasingly large numbers. Not only his former students and fellows but also many others in and around immunology were drawn to the study of DCs. As a result of Ralph’s work, that of his collaborators, as well as an entire new field born of his efforts, we now understand that the DC is the key player in driving immunity. It is essential for the initiation of virtually all antigen-specific adaptive immune responses, and provides the missing link between the innate and adaptive arms of the immune response. DCs capture microbes, bear the pattern recognition receptors for microbial components that cause DC “maturation” (the process that converts DCs from antigen-capture mode to antigen-presentation mode), and secrete the cytokines that polarize T cell responses accordingly. The conceptual framework forged by Ralph’s discovery and analysis of DCs is profound.
        Recognition finally did come for Ralph, in the form of the highly prestigious Gairdner and Lasker Awards in 2003 and 2007, and most recently by the Nobel Prize, which he sadly never got to see. Nevertheless, this affirmation was deeply meaningful for those who knew him and those influenced by his contributions to science.
         It is rare in the modern history of biomedical science to be able to attribute the discovery of a new cell type, much less a transforming new conceptual understanding, to a single individual. Ralph Steinman clearly provides one such example. His life and work were characterized by a singular dedication first and foremost to his family, his work, and to his friends and colleagues.

SOURCE : SCIENCE MAGAZINE VOL 334

Monday, October 31, 2011

U.K. Scientific Papers Rank First in Citations

British scientists have long taken pride in “punching above their weight,” as former U.K. science adviser David King once said, achieving a wide impact with a relatively modest use of public funds. Two reports out last week confirm that reputation. In the first of a planned biennial look at the international standing of British science, the U.K. Department for Business, Innovation and Skills (BIS) released a citation analysis it commissioned from Elsevier, the scientific publishing company. The analysis, according to a BIS statement, found that the United Kingdom “attracts more citations per pound spent in overall research and development than any other country.” A similar analysis, independently produced by Thomson Reuters, supports that basic theme: Scientific papers from Britain have the greatest impact in the world when the six most prolific nations are ranked by average number of citations. The Thomson Reuters report says Britain produced 8% of the world’s research articles and reviews but 17% of the world’s research papers with more than 500 citations and 20% of those with more than 1000 citations.
            The U.K. performance surpasses even that of the United States, which has the world’s best-funded research system, according to Thomson Reuters, which examined trends from 1991 to 2010. Adjusting raw citation data to norms in each field and year of publication, analyst Jonathan Adams found that Britain crossed from second to first rank in 2007. Germany went from fourth place in 1991 to second place in 2010 (knocking the United States down to third place last year). France, Japan, and China follow.
The Thomson Reuters report says that the “rising trajectory” of U.K. research stands in contrast to the U.S. record, which “has at best plateaued in performance and—according to some estimates—is now in decline.” It traces the starting point of the U.K. rise to 1986, when Britain undertook a quality review known as the Research Assessment Exercise. Today, the report says, biological sciences are the strongest area of U.K. research, including “exceptionally high achievements in organismal biology, where the USA suffers.”

SOURCE : SCIENCE MAGAZINE VOL 334
Related Posts Plugin for WordPress, Blogger...

 
Design by Free WordPress Themes | Bloggerized by Lasantha - Premium Blogger Themes | Affiliate Network Reviews